Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Johnson says Ghislaine Maxwell deserves life sentence over Epstein crimes, rejects potential pardon

Related Posts

Prospectus

June 20, 2025

Letter from the CEO: Unlocking the True Value...

March 27, 2025

Grant of Equity Incentives

April 14, 2025

Productivity Commission Says Trump’s Tariffs Will “Redirect” Others...

August 7, 2025

Top 5 Canadian Mining Stocks This Week: Kirkland...

August 9, 2025

Uranium Price Update: Q1 2025 in Review

April 24, 2025

Mario Innecco: Gold Still in Third Inning, When...

June 10, 2025

Allied Critical Metals Announces Frankfurt Stock Exchange Listing

May 16, 2025

Unlocking a New High-Grade Antimony-Tungsten Structure Adds Potential...

February 25, 2025

Kobo Resources: Unlocking West Africa’s Untapped Gold Potential

August 19, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 6

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 7

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved